Progenerative Medical is pleased to announce the enrollment completion of the clinical safety study for its Regenn™ Negative Pressure Therapy System (NPTS). CEO, Neal Vail, said, “This is a major milestone for us, putting us on track to complete the study later this year followed by submission of our FDA application". San Antonio, TX, USA. [...]
PGM is pleased to announce the addition of Dr. Douglas Burton to the Progenerative team. Dr. Burton is a respected spine surgeon with over 25 years of experience in adult and pediatric spine surgery. Dr. Burton previously led PGM’s Medical Advisory Board and has been intimately involved in the development and execution of PGM’s current [...]
PGM is pleased to announce the enrollment of the twentieth patient in its IDE-approved clinical safety study for its Regenn™ Negative Pressure Therapy System (NPTS). "We are pleased with our clinical experience of the Regenn™ NPTS and continue to work with the PGM team to bring this study to a successful completion", Joshua Bunch, MD, Principle Investigator. [...]
PGM is pleased to announce the completion of the first patient in its IDE-approved clinical safety study for its Regenn™ Negative Pressure Therapy System. “Placing the first Regenn™ NPTS device was an honor and I look forward to continuing to work with the Progenerative Medical team as the study progresses”, said the lead surgeon of [...]
Progenerative Medical (PGM) and Johnson & Johnson Medical Devices Companies Center for Device Innovation at Texas Medical Center (CDI @ TMC) have agreed to explore new orthopedic applications based on PGM’s extensive intellectual property portfolio for reduced pressure therapy. The agreement brings engineering teams and resources from both companies together to collaborate on ideation, prototyping, [...]
PGM is pleased to be one of seven companies selected to join the 2021 TMCx accelerator program. Working with TMCx will provide PGM with opportunities to build sustainable relationships with the world class members of TMC Innovation community as we receive customized support from the TMCx team and mentor network. “It is an honor to be [...]
Progenerative Medical has been accepted into the November 2020 cohort of companies that will participate in their accelerator program. The Capital Factory (CF) accepts a limited number of companies into their program; a strong testimonial to their belief in PGM for a high potential for success. Progenertaive Medical will benefit greatly from being a part [...]
Progenerative Medical Inc (PGM) is participating in the virtual Texas Medical Center Bootcamp (TMCx), the first step in the selection process for becoming a part of the next cohort of TMCx resident companies. It's an honor to have been chosen. This gives our company access to mentorship and resources that will help take us to [...]
PGM is pleased to announce the addition of Kien Nguyen to the Progenerative team. Kien played a key role in the early concept development of Regenn™ Therapy while at Kinetic Concepts, Inc., and brings valuable technology and market experience to the PGM team. Over the past 20 years, Kien has worked on the development and commercialization of [...]
Progenerative Medical Obtains Exclusive Rights to Tissue Regeneration Technology Progenerative Medical to develop and commercialize negative pressure therapies for the spine and general orthopedics.San Antonio, TX, USA – September 14, 2016 Progenerative Medical, Inc. (PGM), a clinical-ready medical device company announced today they have entered into a technology licensing agreement with Kinetic Concepts (KCI).The [...]
Stay In Touch